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Abstract
Background: Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) is a powerful method 
for the analysis of gene expression. Target gene expression levels are usually normalized to a consistently expressed 
reference gene also known as internal standard, in the same sample. However, much effort has not been expended 
thus far in the search for reference genes suitable for the study of stomach cancer using RT-qPCR, although selection of 
optimal reference genes is critical for interpretation of results.
Methods: We assessed the suitability of six possible reference genes, beta-actin (ACTB), glyceraldehydes-3-phosphate 
dehydrogenase (GAPDH), hypoxanthine phosphoribosyl transferase 1 (HPRT1), beta-2-microglobulin (B2M), ribosomal 
subunit L29 (RPL29) and 18S ribosomal RNA (18S rRNA) in 20 normal and tumor stomach tissue pairs of stomach cancer 
patients and 6 stomach cancer cell lines, by RT-qPCR. Employing expression stability analyses using NormFinder and 
geNorm algorithms we determined the order of performance of these reference genes and their variation values.
Results: This RT-qPCR study showed that there are statistically significant (p < 0.05) differences in the expression levels 
of HPRT1 and 18S rRNA in 'normal-' versus 'tumor stomach tissues'. The stability analyses by geNorm suggest B2M-
GAPDH, as best reference gene combination for 'stomach cancer cell lines'; RPL29-HPRT1, for 'all stomach tissues'; and 
ACTB-18S rRNA, for 'all stomach cell lines and tissues'. NormFinder also identified B2M as the best reference gene for 
'stomach cancer cell lines', RPL29-B2M for 'all stomach tissues', and 18S rRNA-ACTB for 'all stomach cell lines and tissues'. 
The comparisons of normalized expression of the target gene, GPNMB, showed different interpretation of target gene 
expression depend on best single reference gene or combination.
Conclusion: This study validated RPL29 and RPL29-B2M as the best single reference genes and combination, for RT-
qPCR analysis of 'all stomach tissues', and B2M and B2M-GAPDH as the best single reference gene and combination, for 
'stomach cancer cell lines'. Use of these validated reference genes should provide more exact interpretation of 
differential gene expressions at transcription level in stomach cancer.
Background
Reverse transcription quantitative real-time polymerase
chain reaction (RT-qPCR) is a powerful tool for validating
the observed gene expression differences, because of its
greater sensitivity and specificity. In traditional gene
expression studies, a 'reference gene', also called 'internal
standard' or 'housekeeping gene' is used for the normal-
ization. The expression of beta-actin (ACTB) and glycer-
aldehydes-3-phosphate dehydrogenase (GAPDH), used
in a majority of studies [1], was reported to vary with
experimental conditions [2] and clinical status of the tis-
sue studied (e.g. asthma), making these genes unsuitable
as internal standards for use in normalization of gene
expression [3]. Thus, the validity of the reference gene
chosen for statistical analysis is crucial for avoiding the
hazard of misinterpreting data and invalid conclusions
[4].
It was suggested that at least three considerations
should be taken into account in choosing a reference
gene: 1) constancy of its expression throughout the inter-
vention, 2) its amplification efficiency and 3) its abun-
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dance, which should be similar to that of the genes of
interest [5]. In addition, to ensure the relevance, accuracy
and correctness of interpretations of RT-qPCR, it is rec-
ommended that the precise guidelines for RT-qPCR
MIQE (Minimum Information for Publication of Quanti-
tative Real-Time PCR Experiment) should be adhered to
[6]. Several tools for statistical analysis such as Norm-
Finder [7], geNorm [8], BestKeeper [9] have been devel-
oped to help in the choice of appropriate reference genes.
These tools assess the variations in the expression of a
number of potential reference genes and suggest which
reference gene(s) is appropriate for normalization of gene
expression data in a given study.
Stomach cancer is the fourth most common cancer
worldwide, with a reported 934,000 cases in 2002 [10].
Survival from stomach cancer is poor since patients are
often diagnosed only after the disease has already
advanced significantly [11], which makes early detection
very important. Screening aiming at early detection
involves endoscopic examination. To confirm the pres-
ence of cancer, biopsies are taken from suspected tissues
and subjected to RT-qPCR to confirm abnormal expres-
sion of cancer related genes. But appropriate reference
genes have to be identified for valid comparisons between
expressions of normal versus cancer genes. Reference
genes have been described for RT-qPCR studies in vari-
ous cancers of other tissues [1,12-21]. However there
seems to be no consensus on reference genes for gene
expression studies in stomach cancer. We therefore
searched PubMed with MeSH terms "gastric cancer",
"real-time", and "PCR". In an evaluation of 115 articles
published from May 2007 to November 2009, we found
that GAPDH (53 cases; 46.1%) and ACTB (41 cases;
35.7%) were the most frequently used reference genes in
gastric cancer studies; followed by 18S rRNA (8 cases;
7.0%), beta-2-microglobulin (B2M; 3 cases; 2.6%), hypox-
anthine phosphoribosyl transferase 1 (HPRT1; 2cases;
1.7%), TATA binding protein (TBP; 1 case; 0.9%), and
beta-tubulin (TUBB; 1 case; 0.9%). In five cases (4.3%),
external standard curve was used for absolute quantifica-
tion (AQ) instead of normalized value by reference gene.
The present study has therefore been designed to find
best reference genes for the gene expression studies in
stomach cancer. In this study, we investigated the five ref-
erence genes that have been most frequently used genes
in stomach cancer studies (ACTB, GAPDH, B2M, 18S
rRNA, and HPRT1) and for comparison, RPL29, a refer-
ence gene used in other cancer studies, in 'non-stomach
cancer cell lines', 'stomach cancer cell lines', 'normal
stomach tissues' and 'tumor stomach tissues' (Table 1). In
order to choose the most appropriate reference gene
from the above list, we compared the expressions of gly-
coprotein NMB (GPNMB), our target gene, with those in
the above named list of possible "reference" genes.
Methods
Cell lines and human tissues
We obtained cell lines from American Type Culture col-
lection (Manassas, VA, USA) or Korean Cell Line Bank
(Seoul, Korea): Six stomach tumor cell lines (SNU-216,
SNU-638, SNU-719, AGS, MKN-28 and KATOIII), five
non-stomach cancer cell lines (JIMT1, SK-BR-3, SNU-
C5, A549, and U87), and two normal human cell lines
(HDF, HMEC). All the cell lines were maintained in des-
ignated media (Mediatech, Manassas, VA, USA) supple-
mented with 10% fetal bovine serum (Invitrogen,
Calsbard, CA, USA). Twenty matched pairs of normal
and tumor stomach tissues were obtained by endoscopic
resection during examination of the patients who gave
informed consent (Table 2). All procedures were carried
out in accordance with protocols approved by institu-
tional review board of National Cancer Center and follow
the declaration of Helsinki.
RNA extraction and cDNA synthesis
Stomach cancer tissue samples were preserved in RNAl-
ater solution (Qiagen, Hilden, Germany) until use for
RNA extraction. Total RNA was extracted with TRIzol
regent according to the manufacturer's protocol (Invitro-
gen), and treated with DNaseI on RNeasy Mini column
(Qiagen) to remove residual genomic DNA. Concentra-
tion and A260/280 ratio of purified RNA were measured
with Nanodrop ND-1000 (Thermo Scientific, Wilming-
ton, DE, USA), and quality was assessed on Agilent 2100
Bioanalyzer using RNA 6000 Nano kit (Agilent Technolo-
gies, Santa Clara, CA, USA). Two μg of poly-dT primed
total RNA (random hexamer primed total RNA for 18S
rRNA amplification) were reverse-transcribed with Tran-
scriptor Reverse Transcriptase according to the manufac-
turer's protocol (Roche Applied Science, Mannheim,
Germany).
Reverse transcription quantitative real-time PCR (RT-qPCR)
Based on previous reports, we adopted primers of ampli-
con length below 200 bp, except for ACTB, to maintain
consistency in amplification efficiency (Table 3). The
primers for the amplification of GPNMB were designed
by Primer 3 software http://frodo.wi.mit.edu/primer3/.
We quantified mRNA expression of 6 reference genes and
one target gene by RT-qPCR on a Light-Cycler 480 II
(Roche Applied Science). RT-qPCR reaction was per-
formed using 5 ng of diluted cDNA, 5 pmole of each
primer (Table 3), 5 μl of 2 × Light-Cycler Fast DNA Mas-
terPlus SYBR Green I in final volume of 10 μl. The PCR
cycle conditions were set as follows: pre-incubation for 5
minutes at 95°C followed by 45 cycles, with each cycle
including 15 seconds at 95°C, 30 seconds at 58°C, and 30
seconds at 72°C. Relative quantification was performed
by Light Cycler Software 1.5.0 (Roche Applied Science)Rho et al. BMC Cancer 2010, 10:240
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based on 'Crossing Point' (Cp) value that defines the cycle
number at which the fluorescence signal of the sample
exceeds a background fluorescence value.
Data Analyses
Statistical analyses were performed with GraphPad Prism
V4.03 (GraphPad Software, La Jolla, CA, USA). Normal-
ity was assessed according to Kolmogorov-Smirnov (KS),
D'Agostino-Pearson (DAP), and Shapiro-Wilk (SW) tests.
For the distribution of non-normal distributed groups,
non-parametric Mann-Whitney U-test and Wilcoxon
signed rank test were performed. P-values with p < 0.05
were considered statistically significant. We applied
NormFinder V12 [7] and geNorm™ V3.44 [8] software to
determine the expression values of six candidate refer-
ence genes.
Results
RNA quality assessment
We assessed the quality of RNA used as starting material
in several ways. A260/280 ratio measured by Nanodrop was
Table 1: Potential reference genes evaluated in this study.
Gene symbol GenBank 
Accession No.
Gene name Genomic localization Description
ACTB NM_001101 Beta-actin 7p15-12 Cytoskeletal structural protein
GAPDH NM_002046 Glyceraldehyde-3-
phosphate dehydrogenase
12p13 Oxidoreductase in glycolysis 
and gluconeogenesis
HPRT1 NM_000194 Hypoxanthine 
phosphoribosyl transferase 1
Xq26 Metabolic salvage of purines
B2M NM_004048 Beta-2-microglobulin 15q21.1 Beta-chain of major 
histocompatibility complex 
class I molecules
18S rRNA NR_003286 18S ribosomal RNA 22p12 Ribosome subunit
RPL29 NM_00992 Ribosomal protein L29 3p21.3-p21.2 Structural constituent of 
ribosome
GPNMB NM_001005340 Glycoprotein 
(transmembrane) nmb
7p15||C Involved in growth delay and 
reduction of metastatic 
potential
Table 2: Features of patients who provided stomach cancer tissues.
Number of patients
Number of patients Total 20
Male 14
Female 6
Age at diagnosis (years) Range 34-77
Mean ± SD 60.8 ± 12.1
Disease Stage†
Tumor stage T1 8
T2 8
T3 4
Node stage
N0 8
N1 6
N2 2
N3 4
†Stage classification follows the TNM classification system by International Union Against Cancer (UICC) [27].Rho et al. BMC Cancer 2010, 10:240
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2.08 ± 0.09 (mean ± SD) confirming that the RNA was
pure and protein-free. RNA quality reported as RNA
integrity number (RIN) by RNA 6000 Nano Labchip for
cultured cell line was 9.7 ± 0.2 (mean ± SD), and 7.4 ± 1.0
for patient tissue samples. For the matched pairs of stom-
ach tissue samples, we did not find any statistically signif-
icant difference in either A260/280 ratio between normal
(2.05 ± 0.03) and tumor (2.04 ± 0.05) tissues (paired Stu-
dent's t-test p-value = 0.214) or RIN values between nor-
mal (7.2 ± 0.5) and tumor (7.5 ± 1.4) tissue sample groups
(paired Student's t-test p-value = 0.340).
Expression ranges of candidate reference genes and target 
gene
We performed RT-qPCR and determined the amplifica-
tion efficiency of each primer set (Table 3). The expres-
sion of six candidate reference genes in terms of Cp
values generated from RT-qPCR, are displayed in Figure
1 as scatter plot. The cell lines exhibited a spectrum of Cp
values, representing a wide difference in expression, rang-
ing between 14.56 and 34.89, depending on the reference
gene used. ACTB and GAPDH showed most abundant
expression in both 'stomach cancer cell lines' and 'non-
stomach cancer cell lines', but in contrast HPRT1 showed
lowest expression level. The expression of target gene
GPNMB in Cp values ranged from 27.7 to 32.1 in cell
lines. The normality assessment showed HPRT1 in 'stom-
ach cancer cell lines' and 18S rRNA in 'non-stomach cell
lines' are not normally distributed by KS-test. Thus, we
applied non-parametric Mann-Whitney U-test for com-
paring non-normal distributed unmatched groups, and it
showed significant differences in the expressions of
GAPDH (p = 0.014) and B2M (p = 0.035) between 'stom-
ach cancer cell lines' and 'non-stomach cancer cell lines'.
Human stomach tissues also showed wide variations in
Cp values ranging from 13.3 to 29.4 (Figure 1), with high-
est expression of B2M and 18S rRNA and lowest expres-
sion of HPRT1. The expression of target gene GPNMB in
Cp ranged from 28.5 to 34.7 in stomach tissues. In nor-
mality test, ACTB, HPRT1, and 18S rRNA in 'normal
stomach tissues' group and all genes except for GAPDH
in 'tumor stomach tissues' followed normal distribution
by KS-test. HPRT1, B2M, and RPL29 in tumor stomach
tissues passed the normality in DAP- and SW-tests. Thus,
for comparing non-normal distributed paired groups, we
performed non-parametric Wilcoxon signed rank test.
Significant expression increase from normal to tumor
stomach tissues (p < 0.05) were observed in HPRT1 (p =
0.011) and 18S rRNA (p = 0.021), but not in ACTB (p =
0.058), GAPDH (p = 0.918), B2M (p = 0.740), or RPL29 (p
= 0.208).
Expression stability of candidate reference genes
In order to identify the most stable reference genes, we
analyzed the expression data with geNorm and Norm-
Finder. We categorized the cell lines and tissues into the
following groups - 'non-stomach cancer cell lines', 'stom-
ach cancer cell lines', 'normal stomach tissues', 'tumor
stomach tissues', 'all stomach tissues (normal + tumor
stomach tissues)' and 'all stomach cancer cell lines and
tissues'. The application of geNorm with default limit (M
< 1.5) ruled out unstable reference genes and left minimal
Table 3: Primers for six reference genes and a target gene.
Gene Forward primer [5'T3']
Reverse sequence [5'T3']
Anchoring
Exons
Amplicon
size
Spanning on
genome
Amplification
efficiency
Reference
ACTB CATCGAGCACGGCATCGTCA
TAGCACAGCCTGGATAGCAAC
Exon 3
Exon 4
211 bp 652 bp 1.971 [28]
GAPDH TGCACCACCAACTGCTTA
GGATGCAGGGATGATGTTC
Exon 7
Exon 8
177 bp 370 bp 1.999 [29]
HPRT1 AGACTTTGCTTTCCTTGGTCAG
TCAAGGGCATATCCTACAACAA
Exon 6
Exon 8
151 bp 5120 bp 1.949 [30]
B2M ACTGAATTCACCCCCACTGA
CCTCCATGATGCTGCTTACA
Exon 2
Exon 4
114 bp 741 bp 1.924 [28]
18S rRNA GTAACCCGTTGAACCCCATT
CCATCCAATCGGTAGTAGCG
NA1 151 bp 151 bp 2.000 [31]
RPL29 GGCGTTGTTGACCCTATTTC
GTGTGTGGTGTGGTTCTTGG
Exon 1
Exon 2
120 bp 507 bp 1.937 [16]
GPNMB TGCGTCCGTGAGAATTCA
TGTGCTCCCTCATGTAAGCA
Exon 1
Exon 2
144 bp 6522 bp 1.945 In house 
design2
1. Not available
2. Primers were designed by Primer 3 with human mispriming library screening options.Rho et al. BMC Cancer 2010, 10:240
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number of suitable reference genes for each group in the
end (Figure 2). To determine the optimal number of
genes required for geometric mean normalization, we
compared pair-wise variation (Vn/Vn+1) calculated by
geNorm between each combination of sequential nor-
malization factors (NFn and NFn+1) for all samples in the
group. We applied default threshold (0.15) for cut-off [8]
below which inclusion of additional reference genes is not
necessary. In all groups evaluated in this study, the pair-
wise variations are already below the threshold (Figure 3),
thus it was interpreted that using more than two optimal
genes are not beneficial to improve accuracy. On the
other hand, we found a correlation between variance and
slope of the M-value curve. In the case of 'non-stomach
cancer cell lines', addition of GAPDH as the third gene to
the two optimally expected genes B2M-RPL29 increases
by 0.0218 of the stability value M, with its pair-wise vari-
ance V2/3 of 0.032. In this manner, the coefficient of the
correlation between pair-wise variation and the incre-
ment of M-value at each interval in this group was deter-
mined to be r2 = 0.956. For 'stomach cancer cell lines,' the
higher V4/5 (0.018) and V5/6 (0.028) values than V2/3 or V3/
4 explain why the high-scoring HPRT1 and ACTB genes
should be excluded. The correlation coefficient was r2 =
0.895. The correlation coefficients in 'normal stomach
tissues', 'tumor stomach tissues' and 'all stomach tissues'
were r2 = 0.971, 0.996 and 0.960, respectively. In 'all stom-
ach cancer cell lines and tissues', it showed less correla-
tion (r2 = 0.718).
We also applied NormFinder program to the same data
sets and calculated stability values. As shown in Table 4,
the lowest stability value indicates most stable expression
and we ranked genes accordingly. The best single refer-
ence gene for each group is as follows; 'non-stomach can-
cer cell lines' - GAPDH (0.036), 'stomach cancer cell lines'
- B2M (0.014), 'normal stomach tissues' - RPL29 (0.028),
'tumor stomach tissues' - RPL29 (0.028), 'all stomach tis-
sues' - RPL29 (0.032) and 'all stomach cell lines and tis-
sues' - ACTB (0.029). The rank of reference genes for
'stomach cancer cell lines' was identical with that from
the geNorm analysis, but was slightly different in other
categories. NormFinder also estimates the best combina-
tion of reference genes by sub-grouping in 'all stomach
tissues' - RPL29-B2M (0.005) and in 'all stomach cell lines
and tissues' - 18S rRNA-B2M (0.013).
Figure 1 Expression levels for six candidate reference genes detected by RT-qPCR. Crossing point (Cp) values in 'stomach cancer cell lines' and 
'non-stomach cancer cell lines', 'normal stomach tissues' and 'tumor stomach tissues' are represented as expression level. Horizontal bar in the middle 
of scattered spots indicates average expression level. The lower the Cp value, the higher is the expression of genes.Rho et al. BMC Cancer 2010, 10:240
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Target gene expression profiles are influenced by reference 
genes employed for normalization
For the evaluation of the reference genes in real situation,
we chose 'stomach cancer cell lines', 'all stomach tissues'
and 'all stomach cell lines and tissues' because cancer
researchers' focus on comparing gene expression in nor-
mal and tumor tissues as well as stomach originated can-
cer cell lines for in vitro study. We applied single
reference genes and combinations in the relative quantifi-
cation (RQ) of GPNMB as a target gene. GPNMB is a
transmembrane glycoprotein and plays a cooperative role
with p53 and cytokine-mediated transcription factors in
differentiated immune cells [22] and breast cancer [23].
The RQ of GPNMB expression by each six single refer-
ence genes and B2M-GAPDH combination in 'stomach
cancer cell lines' was compared (Figure 4). The RQs by
B2M, GAPDH as single reference gene and B2M-GAPDH
that were predicted to be the most optimal combination
of reference genes for 'stomach cancer cell lines' by
geNorm showed similar high-low patterns (Figure 4A, B
and 4G). In comparison, the RQ by RPL29 resulted in an
apparently elevated expression in SNU-216 but reduced
expression in SNU-719 cell lines (Figure 4C). The RQ by
18S rRNA also showed elevated expression in SNU-216
but lowered expression in MKN-28 (Figure 4D). The RQ
by ACTB and HPRT1 showed extremely reduced expres-
sion in SNU-719 and KATOIII (Figure 4E and 4F).
The difference of GPNMB RQ between normal and
tumor stomach tissues was patient dependent. RQ is
higher in some tumors but opposite in others. The RQ
normalized by each six single reference gene did not
show the same exact pattern. In case of normalization by
RPL29 which was predicted as most stable single refer-
ence gene in NormFinder and most stable combination
with HPRT1 in geNorm, the high-low pattern of RQ dif-
ference between normal and tumor (Figure 5A) was simi-
lar to RQ by HPRT1 though there were difference in three
patients (Figure 5B). The RQ by B2M (Figure 5c) and 18S
rRNA (Figure 5d) showed different pattern from highly
ranked single reference genes in more patients. With
ACTB (Figure 5E) GAPDH (Figure 5F), the difference
became greater; there were differences in 35% of total
patients. The RQ normalized by geometric means of
RPL29-HPRT1 combination from geNorm (Figure 5G)
and RPL29-B2M from NormFinder (Figure 5H) showed
similar pattern. When the overall fold change (Tumor/
Normal) was compared, RQ of GPNMB by B2M (T/N =
2.46×, paired t-test p = 0.017) and RPL29-B2M (T/N =
2.08×, p = 0.025) showed significant increase from nor-
mal to tumor stomach tissues. RQ by RPL29 (T/N =
2.23×, p = 0.071), HPRT1 (T/N = 1.34×, p = 0.258), ACTB
(T/N = 1.60×, p = 0.395), 18S rRNA (T/N = 1.36×, p =
0.527) and RPL29-HPRT1 (T/N = 1.76×, p = 0.086) also
showed increasing GPNMB expression in tumor stomach
tissues but it was not statistically significant. In compari-
son, it showed opposite direction of expression difference
(T/N = 0.75×, p = 0.637) by GAPDH. This suggests that
GAPDH expression in tumor stomach tissues are highly
elevated compared to the other reference genes. These
results also suggest that RQ data of target gene could be
interpreted in different ways depending on the reference
genes used for normalization.
For the 'all stomach cancer cell lines and tissues', Norm-
Finder and geNorm predicted 18S rRNA-B2M and 18S
rRNA-ACTB as the best combinations. The pattern of
GPNMB RQ by geometric mean of these combinations
was similar between them. GPNMB RQs between 'stom-
ach cancer cell lines' and 'all stomach tissues' could be
compared within same range with 18S rRNA-ACTB, but
there was 1 log of order difference by 18S rRNA-B2M
combination. Patterns of RQ in 'stomach cancer cell lines'
(Figure 6A, 6B) were similar to RQ by B2M-GAPDH (Fig-
ure 4G), but RQ of 'all stomach tissues' by 18S rRNA-
ACTB (Figure 6B) were different from (Figure 5G, 5H). It
appears that significantly increased 18S rRNA expression
in tumor stomach tissues (Figure 1) could contribute to
this result. Thus, though these combinations were pre-
dicted as best, they are not suitable for the interpretation
of data.
Discussion
Differential gene expression in cancer identified from
transcriptome study suggests that some specific genes
might be involved in tumorigenesis and metastasis of
cancer. RT-qPCR is a robust and specific method for the
validation of the identity of candidate genes of stomach
cancer, because it detects even very weak signals from
extremely small amounts of biopsied samples if the
patient is in early stage of cancer. However, in the absence
of appropriate reference genes, data obtained are open to
question leading to misinterpretation. Prior to this study,
no validated reference gene has been identified for 'stom-
ach cancer cell line' or 'stomach cancer tissue', but ACTB
and GAPDH have been used most frequently until now
without consideration of their inconsistent expressions in
different experimental settings and clinical conditions.
We examined, in addition to ACTB and GAPDH, four
other reference genes, HPRT1, RPL29, 18S rRNA, and
B2M that have been evaluated as reference genes in
recent studies for other human cancers.
It is evident that choosing appropriate primer set is an
important starting point to obtain accurate results. We
considered following points in selecting primers. First, we
adopted primer sets that were previously reported to
have or designed to possess an amplicon length around
200 bp. Second, all of the primer sets were required to
span at least two neighboring exons except for 18S rRNA
gene which is not an mRNA. The above two points areRho et al. BMC Cancer 2010, 10:240
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related to the amplification efficiency. It is necessary that
reference gene and target gene maintain similar amplifi-
cation efficiency [13]. Amplicon length is closely related
to amplification efficiency [24]. So one would expect sim-
ilar efficiency from amplicon of similar length, and higher
efficiency from a shorter amplicon. The benefit of shorter
amplicon, 70-250 bp, in RT-qPCR is that amplification is
"independent" of RNA quality [25]. The amplification
Figure 2 Average expression stability (M) of six candidate reference genes by geNorm analyses. Expression stability were plotted in 'non-stom-
ach cancer cell lines' (A), 'stomach cancer cell lines' (B), 'normal stomach tissues' (C), 'tumor stomach tissues' (D), 'all stomach tissues' (E) and 'all stom-
ach cancer cell line and tissues' (F). The least stable reference gene (higher M value) is on the left and the most stable combination (lower M value) is 
on the right of the plot. Most stable reference genes were deduced by stepwise exclusion of the least stable genes.Rho et al. BMC Cancer 2010, 10:240
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e f f i c i e n c y  i s  a l s o  a f f e c t e d  b y  g D N A  c o n t a m i n a t i o n ,
because competitive binding of primers acts as a limiting
factor causing decrease of amplification efficiency [13]. In
this context, DNaseI treatment during the RNA purifica-
tion is crucial to avoid amplification from residual gDNA,
but it might not be totally effective. Therefore, our sec-
ond consideration helps to detect possible contamination
with gDNA with different amplicon sizes. We confirmed
that each forward and reverse primer is anchored on dif-
f e r e n t  e x o n  b y  B L A T  s e a r c h e s  o n  h u m a n  g e n o m e
sequences and also that there was no amplified product
from contaminating gDNA with extended amplicon
length (Table 2). Besides, we also ensured the high quality
of RNA, the starting material, in several ways. We also
performed the experiments in triplicate for every gene
and every sample.
Since the development of qPCR, several statistical pro-
grams were developed to identify optimal reference
genes. We chose geNorm and NormFinder to analyze the
stability of the six reference genes we studied. The
geNorm program calculates M-values based on the aver-
age pair-wise variation of a particular gene compared
with all other studied candidate reference genes and
ranks them [8]. In comparison, NormFinder adopts a
strategy , called 'model-based approach to estimation of
expression variation' [7]. These distinct strategies identi-
fied for us the best single or combination reference genes
in each group of comparisons. GeNorm identified
RPL29-HPRT1 as the most optimal combination for 'all
stomach tissues', while NormFinder identified RPL29-
B2M instead. Although HPRT1 or B2M was in the best
combination identified both by geNorm and NormFinder,
respectively, they were ranked third in our single refer-
ence gene ranking by each analysis (Table 4). With 'stom-
ach cancer cell lines', the rankings from two analyses were
identical, i.e. GAPDH-B2M was the most stable reference
gene combination followed by RPL29. These results were
supported by statistical data, because the highly ranked
reference genes have narrower range of variations in
expression levels (Figure 1). For example, the most unsta-
ble gene, HPRT1, in 'stomach cancer cell lines' has much
wider range of expression compared to GAPDH or B2M.
This is also true for 'all stomach tissues', since RPL29 and
HPRT1 have much narrower range of expression than
GAPDH or ACTB.
Some reference genes such as ACTB and B2M are
expressed somewhat more in stomach tissues than in
cancer cell lines. Cancer cell lines are supposed to be
more activated in metabolism, eventually displaying
higher transcription activities. However, higher expres-
sion of ACTB and B2M was reported in stomach tissues
than AGS/SNU-638 stomach cancer cell lines [26] as well
as higher B2M expression in liver tissues than HepG2/
Hep3B/SK-HEP-1/SNU-182 liver cancer cell lines [17]. In
comparison, in this study, the average expression levels of
GAPDH and RPL29 were similar in stomach tissues and
cancer cell lines. Thus, it appears that metabolically more
Figure 3 Pair-wise variation analysis of six candidate reference 
genes. Pair-wise variation value (Vn/n+1) was generated by geNorm 
analysis. Optimal number of genes was estimated by comparing Vn/n+1. 
All the variations were under the default limit of 0.15.
Table 4: Ranking of the candidate single reference genes based on their stability values calculated from NormFinder.
Non-stomach 
cancer cell lines
Stomach cancer cell 
lines
Normal stomach 
tissues
Tumor stomach 
tissues
All stomach tissues All stomach cell 
lines + tissues
Gene in 
ranking 
order
Stability 
value
Gene in 
ranking 
order
Stability 
value
Gene in 
ranking 
order
Stability 
value
Gene in 
ranking 
order
Stability 
value
Gene in 
ranking 
order
Stability 
value
Gene in 
ranking 
order
Stability 
value
GAPDH 0.036 B2M 0.014 RPL29 0.028 RPL29 0.028 RPL29 0.032 ACTB 0.029
RPL29 0.052 GAPDH 0.021 B2M 0.035 B2M 0.039 B2M 0.041 HPRT1 0.038
B2M 0.053 RPL29 0.029 HPRT1 0.038 HPRT1 0.042 HPRT1 0.044 RPL29 0.068
HPRT1 0.110 18S rRNA 0.036 ACTB 0.043 ACTB 0.065 ACTB 0.052 18S rRNA 0.071
18S rRNA 0.112 ACTB 0.060 18S rRNA 0.062 18S rRNA 0.067 18S rRNA 0.055 GAPDH 0.082
ACTB 0.143 HPRT1 0.115 GAPDH 0.140 GAPDH 0.147 GAPDH 0.140 B2M 0.084Rho et al. BMC Cancer 2010, 10:240
http://www.biomedcentral.com/1471-2407/10/240
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Figure 4 Relative quantification of GPNMB expression in stomach cancer cell lines depends on different reference genes. The GPNMB ex-
pression in six stomach cancer cell lines were normalized by six single reference genes and best combination derived by geNorm (mean ± SD); nor-
malized by B2M (A), by GAPDH (B), by RPL29 (C), by 18S rRNA (D), by ACTB (E), HPRT1 (F) and geometric mean of B2M-GAPDH combination (G).Rho et al. BMC Cancer 2010, 10:240
http://www.biomedcentral.com/1471-2407/10/240
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Figure 5 Relative quantification of GPNMB expression in normal and tumor stomach tissues depends on different reference genes. The GP-
NMB expression in stomach cancer tissues (solid bar: Normal, open bar: Tumor) were normalized by six single reference genes and two combinations 
derived from geNorm and NormFinder (mean ± SD); normalized by RPL29 (A), by HPRT1 (B), by B2M (C), by 18S rRNA (D), by ACTB (E), GAPDH (F), geo-
metric mean of RPL29-HPRT1 (G) and RPL29-B2M (H).Rho et al. BMC Cancer 2010, 10:240
http://www.biomedcentral.com/1471-2407/10/240
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activated cancer cells are not always in higher transcrip-
tional activity for every gene and every kinds of cell line.
To determine the best reference genes, we analyzed our
results with the six candidate reference genes under the
suggested rules [5]. First, in terms of amplification effi-
ciency, all primer sets seem acceptable because they have
similar and close to perfect amplification efficiency of 2.0
(Table 2). Second, in terms of constant expression in
comparable conditions, HPRT1 and 18S rRNA are to be
excluded from the best candidate list for comparing gene
expression in normal and tumor stomach tissues',
because statistical analysis revealed a significant increase
in gene expression in tumor tissues compared to normal
t i s s u e s.  T h i r d ,  i n  t e r m s  o f  t h e  a b u n d a n c e  o f  r e f e r e n c e
genes and target gene, ideally the reference should be
almost same in its abundance. However, in reality it is
hard to find out genes showing exactly same amount of
expression. Therefore, it is advisable to use the lesser dif-
ferent reference gene to give out the more accurate inter-
pretation. In agreement with this, RPL29 seems
appropriate because the expression is close to that of
GPNMB. Lastly, in selecting the best reference genes
from two algorithms, we considered whether selecting
multiple reference genes in combination is better than
selecting a single reference gene alone, because there is
still considerable difference of opinion on the use of mul-
tiple reference genes as reported in several studies [13].
Since some of the genes included in combination were
shown to be differentially expressed between normal and
tumor or stomach cancer cell lines and tissues, it is neces-
sary to take into account the consistency of expression
ranges of each reference gene. Although RPL29-HPRT1
combination has been suggested as the best for 'all stom-
a c h  t i s s u e s '  b y  g e N o r m ,  i t  i s  a l s o  ev i d e n t  t h a t  H P R T 1
expression has increased from normal to tumor and this
combination is not considered suitable one. In this con-
text, it is not advisable to accept the best combinations
for 'all stomach cancer cell lines and tissues'. Both algo-
rithms suggested combinations that have 18S rRNA
showing differences in the levels of expression between
normal and tumor stomach tissues. Actually, only RPL29
showed consistent expression range for all stomach can-
Figure 6 Relative quantification of GPNMB expression in the pool of all stomach cancer cell lines and tissues depends on different combi-
nations of reference genes. The GPNMB expression in stomach cancer cell lines and stomach tissues (solid bar: Normal, open bar: Tumor) were nor-
malized by two combinations derived from geNorm and NormFinder (mean ± SD); normalized by 18S rRNA-ACTB in stomach cancer cell lines (A) and 
stomach tissues (C) and normalized by 18S rRNA-B2M in stomach cancer cell line (B) and stomach tissues (D).Rho et al. BMC Cancer 2010, 10:240
http://www.biomedcentral.com/1471-2407/10/240
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cer cells and tissues, suggesting that using single refer-
ence gene may be more appropriate for comparisons.
Taking these findings together, B2M seems to be the most
suitable single reference gene for 'stomach cancer cell
lines' and RPL29 for 'all stomach tissues'. RPL29 is also
the best for comparing target gene expressions in stom-
ach cancer cells and tissues. Using GAPDH-B2M combi-
nation for comparing gene expressions in 'stomach
cancer cell lines' and RPL29-B2M combination for com-
paring in 'all stomach tissues' is therefore recommended.
We recognize the limitation of this study in that we exam-
ined a limited number of samples, but we feel that our
conclusions and recommendations are supported in part
by previously deposited expression data from microarray
and reports in the literature. In an asthmatic airway
study, ACTB and GAPDH were found to be unsuitable as
reference genes [4]. Same conclusion was reported for
breast, prostate and pancreatic cancers where transcript
levels of GAPDH were found elevated [15]. For stomach
tissues, we confirmed this in microarray data deposited in
ArrayExpress Gene Expression ATLAS http://
www.ebi.ac.uk/arrayexpress. The gene expression profile
of advance gastric cancer tissues (E-GEOD-2685) showed
elevated expression in ACTB (p-value = 7.73e-3) and
GAPDH (p-value = 1.94e-3), but no significant difference
with other four candidate reference genes. For the target
gene GPNMB, elevation of expression was observed in
primary gastric tumors (p-value = 1.11e-8; E-GEOD-
15460). Thus, it seems clear that blindly choosing just
ACTB or GAPDH without such evaluations should be
avoided.
Conclusion
In this study we systematically explored the suitability of
potential candidate reference genes for normalization of
gene expression in stomach cancer cell lines and tissues.
We propose B2M and RPL29 as the best single reference
genes for exploring gene expression in 'stomach cell lines'
and 'all stomach tissues', respectively. In addition we sug-
gest that GAPDH-B2M combination for normalizing
expression in 'stomach cancer cell lines' and RPL29-B2M
combination for comparison between normal and tumor
in 'all stomach tissues'. RPL29 is also suitable for the com-
parison in pooled stomach cancer cell lines and tissue
samples. The choice of reference genes should depend on
the cell lines and/or tissues under study, and there is no
single, universal, common optimal reference gene.
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